Efficacy and Safety of Alfuzosin for the Treatment of Voiding Dysfunction in Female

PHASE2CompletedINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

December 31, 2009

Conditions
Voiding Dysfunction
Interventions
DRUG

alfuzosin hydrochloride XL 10mg

One tablet to be taken daily after a meal before bedtime for 8 weeks.

DRUG

Placebo

One tablet to be taken daily after a meal before bedtime for 8 weeks.

Trial Locations (9)

135-710

Samsung Medical Center, Seoul

Unknown

Chungnam National University Hospital, Daejeon

420-717

Holy Family Hospital, The Catholic University of Korea, Kyonggi-do

602-739

Pusan National University Hospital, Pusan

100-380

Cheil General Hospital & Women's Healthcare Center, College of Medicine, Kwandong University, Seoul

110-744

Seoul National University Hospital, Seoul

136-705

Anam Hospital, College of Medicine, Korea University, Seoul

137-701

Kangnam St. Mary's Hospital, The Catholic University of Korea, Seoul

138-736

Asan Medical Center, Ulsan College of Medicine, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Handok Inc.

INDUSTRY

collaborator

The Korean Urological Association

OTHER

lead

Samsung Medical Center

OTHER

NCT00679315 - Efficacy and Safety of Alfuzosin for the Treatment of Voiding Dysfunction in Female | Biotech Hunter | Biotech Hunter